Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-03-25

FDA Approved: ZYCLARA — Original Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved ZYCLARA (imiquimod) 3.75% cream from Bausch Health US, LLC as an Original Application (NDA022483). The product is approved for actinic keratosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZYCLARA (Imiquimod)

Snippet

ORIG AP for ZYCLARA (IMIQUIMOD)